![A Protocol for the Perioperative Management of Patients With Intracoronary Drug-Eluting Stents - Anesthesia Patient Safety Foundation A Protocol for the Perioperative Management of Patients With Intracoronary Drug-Eluting Stents - Anesthesia Patient Safety Foundation](https://www.apsf.org/wp-content/uploads/newsletters/2007/winter/images/12_drawing.jpg)
A Protocol for the Perioperative Management of Patients With Intracoronary Drug-Eluting Stents - Anesthesia Patient Safety Foundation
![Drug-eluting or bare-metal stents for percutaneous coronary intervention: a systematic review and individual patient data meta-analysis of randomised clinical trials - The Lancet Drug-eluting or bare-metal stents for percutaneous coronary intervention: a systematic review and individual patient data meta-analysis of randomised clinical trials - The Lancet](https://www.thelancet.com/cms/attachment/00a18de6-fd57-4214-a8ee-a6657b99bc47/gr1.gif)
Drug-eluting or bare-metal stents for percutaneous coronary intervention: a systematic review and individual patient data meta-analysis of randomised clinical trials - The Lancet
![Drug-eluting stents in large coronary vessels improve both safety and efficacy compared with bare-metal stents in women: a pooled analysis of the BASKET-PROVE I and II trials | Open Heart Drug-eluting stents in large coronary vessels improve both safety and efficacy compared with bare-metal stents in women: a pooled analysis of the BASKET-PROVE I and II trials | Open Heart](https://openheart.bmj.com/content/openhrt/6/1/e000986/F1.large.jpg)
Drug-eluting stents in large coronary vessels improve both safety and efficacy compared with bare-metal stents in women: a pooled analysis of the BASKET-PROVE I and II trials | Open Heart
![The National Pharmaceutical Pricing Authority (NPPA) has approved a hike in the price of coronary stents (bare metal stents as well as of Drug eluting/biodegradable stents). Last year, the Central government slashed The National Pharmaceutical Pricing Authority (NPPA) has approved a hike in the price of coronary stents (bare metal stents as well as of Drug eluting/biodegradable stents). Last year, the Central government slashed](https://vajiramandravi.s3.us-east-1.amazonaws.com/media/2019/4/2/16/11/13/stents.jpg)
The National Pharmaceutical Pricing Authority (NPPA) has approved a hike in the price of coronary stents (bare metal stents as well as of Drug eluting/biodegradable stents). Last year, the Central government slashed
![ESC 2016: Drug-eluting stents are still preferred despite no long-term survival advantage over bare metal stents - Cardiovascular News ESC 2016: Drug-eluting stents are still preferred despite no long-term survival advantage over bare metal stents - Cardiovascular News](https://cardiovascularnews.com/wp-content/uploads/sites/14/2016/09/DES-Generic.jpg)
ESC 2016: Drug-eluting stents are still preferred despite no long-term survival advantage over bare metal stents - Cardiovascular News
![Drug-Eluting Stents Versus Conventional Endovascular Therapies in Symptomatic Infrapopliteal Peripheral Artery Disease: A Meta-analysis - ScienceDirect Drug-Eluting Stents Versus Conventional Endovascular Therapies in Symptomatic Infrapopliteal Peripheral Artery Disease: A Meta-analysis - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2772930322000072-fx1.jpg)
Drug-Eluting Stents Versus Conventional Endovascular Therapies in Symptomatic Infrapopliteal Peripheral Artery Disease: A Meta-analysis - ScienceDirect
![Does Large Vessel Size Justify Use of Bare-Metal Stents in Primary Percutaneous Coronary Intervention? | Circulation: Cardiovascular Interventions Does Large Vessel Size Justify Use of Bare-Metal Stents in Primary Percutaneous Coronary Intervention? | Circulation: Cardiovascular Interventions](https://www.ahajournals.org/cms/asset/057aae6e-5ca6-4d62-88d2-299229b08ae3/e007705fig05.jpg)
Does Large Vessel Size Justify Use of Bare-Metal Stents in Primary Percutaneous Coronary Intervention? | Circulation: Cardiovascular Interventions
![Drug-eluting stents versus bare-metal stents in acute myocardial infarction with cardiogenic shock | Heart Drug-eluting stents versus bare-metal stents in acute myocardial infarction with cardiogenic shock | Heart](https://heart.bmj.com/content/heartjnl/103/15/1177/F1.large.jpg)
Drug-eluting stents versus bare-metal stents in acute myocardial infarction with cardiogenic shock | Heart
![Aisha Shaikh @aisha.shaikh.md on Threads on X: "⚡️Bare Metal Stents & Nitinol Stents have problems because the tissue in-growth through the bare metal causes restenosis ⚡️Covered Stents (Stent-Grafts) theoretically form a barrier, Aisha Shaikh @aisha.shaikh.md on Threads on X: "⚡️Bare Metal Stents & Nitinol Stents have problems because the tissue in-growth through the bare metal causes restenosis ⚡️Covered Stents (Stent-Grafts) theoretically form a barrier,](https://pbs.twimg.com/media/EpsDDd6WMAAEKOg.jpg:large)
Aisha Shaikh @aisha.shaikh.md on Threads on X: "⚡️Bare Metal Stents & Nitinol Stents have problems because the tissue in-growth through the bare metal causes restenosis ⚡️Covered Stents (Stent-Grafts) theoretically form a barrier,
![What Type of Stent Should Be Used to Treat Patients With STEMI? Part I: Bare Metal Stents (BMS) Remains the First Choice in ST-elevation Myocardial Infarction (STEMI) - American College of Cardiology What Type of Stent Should Be Used to Treat Patients With STEMI? Part I: Bare Metal Stents (BMS) Remains the First Choice in ST-elevation Myocardial Infarction (STEMI) - American College of Cardiology](https://www.acc.org/-/media/Non-Clinical/Images/Latest-in-Cardiology/Articles/2015/10/EA_2015Oct26_Finn_Fig1.png?la=en&hash=098C950F4DCA715C49E9307FE58900109973B64D)
What Type of Stent Should Be Used to Treat Patients With STEMI? Part I: Bare Metal Stents (BMS) Remains the First Choice in ST-elevation Myocardial Infarction (STEMI) - American College of Cardiology
![Balloon expandable coronary stent materials: a systematic review focused on clinical success | SpringerLink Balloon expandable coronary stent materials: a systematic review focused on clinical success | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs44164-022-00009-w/MediaObjects/44164_2022_9_Fig1_HTML.png)